Evaluation of the risk for Tay-Sachs disease in individuals of French Canadian ancestry living in New England

Clinical Chemistry

Volumn 53, Issue 3, 2007, Pages 392-398

  Martin, Dianna C ^a   Mark, Brian L ^a   Triggs Raine, Barbara L ^a,b   Natowicz, Marvin R ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; FLUORESCENCE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; HEREDITY; HETEROZYGOSITY; HUMAN; NONHUMAN; PLESIOMORPHY; RISK FACTOR; TAY SACHS DISEASE;

ADULT; BETA-HEXOSAMINIDASE ALPHA CHAIN; BETA-N-ACETYLHEXOSAMINIDASES; CANADA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MASSACHUSETTS; MUTATION; RISK; TAY-SACHS DISEASE;

EID: 33947412698     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.082727     Document Type: Article

References (40)

1. M2-gangliosidoses and the elucidation of the β-hexosaminidase system. Adv Genet 2001;44:67-91.
2. Kaback MM, Shapiro U, Hirsch P, Roy C. Tay-Sachs disease heterozygote detection: a quality control study. Prog Clin Biol Res 1977;18:267-79.
3. Kaback MM. Thermal fractionation of serum hexosaminidases: applications to heterozygote detection and diagnosis of Tay-Sachs disease. Meth Enzymol 1972;28:862-7.
4. Andermann E, Scriver CR, Wolfe LS, Dansky L, Andermann F. Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff's disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French-Canadian population. Prog Clin Biol Res 1977;18:161-88.
5. Bach G, Navon R, Zeigler M, Beyth Y, Porter B, Cohen MM. Tay-Sachs disease in a Moroccan Jewish family: a possible new mutation. Isr J Med Sci 1976;12:1432-9.
6. Kelly TE, Chase GA, Kaback MM, Kumor K, McKusick VA. Tay-Sachs disease: high gene frequency in a non-Jewish population. Am J Hum Genet 1975;27:287-91.
7. McDowell GA, Mules EH, Fabacher P, Shapira E, Blitzer MG. The presence of two different infantile Tay-Sachs disease mutations in a Cajun population. Am J Hum Genet 1992;51:1071-7.
8. Prence EM, Jerome CA, Triggs-Raine BL, Natowicz MR. Heterozygosity for Tay-Sachs and Sandhoff diseases among Massachusetts residents with French Canadian background. J Med Screen 1997;4:133-6.
9. Triggs-Raine BL, Richard M, Wasel N, Prence EM, Natowicz MR. Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England. Am J Hum Genet 1995;56:870-9.
10. Karpati M, Gazit E, Goldman B, Frisch A, Colombo R, Peleg L. Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor. Neurogenetics 2004;5:35-40.
11. Branda KJ, Tomczak J, Natowicz MR. Heterozygosity for Tay-Sachs and Sandhoff diseases in non-Jewish Americans with ancestry from Ireland, Great Britain, or Italy. Genet Test 2004;8:174-80.
12. Triggs-Raine BL, Feigenbaum AS, Natowicz M, Skomorowski MA, Schuster SM, Clarke JT, et al. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. N Engl J Med 1990;323:6-12.
13. Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K. Tay-Sachs disease-carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network. JAMA 1993;270: 2307-15.
14. Cao ZM, Petroulakis E, Salo T, Triggs-Raine BL. Benign HEXA mutations, C739T(R247W) and C745T(R249W), cause β-hexosaminidase A pseudodeficiency by reducing the α subunit protein levels. J Biol Chem 1997;272:14975-82.
15. Triggs-Raine BL, Mules EH, Kaback MM, Lim-Steele JS, Dowling C, Akerman B, et al. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening. Am J Hum Genet 1992;51:793-801.
16. Cao Z, Natowicz M, Kaback M, Lim-Steele J, Prence E, Brown D, et al. A second mutation associated with apparent β-hexosaminidase A pseudodeficiency: identification and frequency estimation. Am J Hum Genet 1993;53:1198-205.
17. Prence EM, Natowicz MR, Zalewski I. Unusual thermolability properties of leukocyte β-hexosaminidase: implications in screening for carriers of Tay-Sachs disease. Clin Chem 1993;39: 1811-4.
18. Hoar DI, Haslam DB, Starozik DM. Improved direct molecular diagnosis and rapid fetal sexing. Prenat Diagn 1984;4:241-7.
19. Myerowitz R, Hogikyan ND. A deletion involving Alu sequences in the β-hexosaminidase α-chain gene of French Canadians with Tay-Sachs disease. J Biol Chem 1987;262:15396-9.
20. M2 gangliosidosis, the adult form of Tay-Sachs disease. Science 1989;243:1471-4.
21. Paw BH, Kaback MM, Neufeld EF. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the α-subunit of β-hexosaminidase. Proc Natl Acad Sci U S A 1989; 86:2413-7.
22. M2 gangliosidosis caused by an apparently silent HEXA mutation (V324V) that results in aberrant splicing and reduced HEXA mRNA. Am J Med Genet A 2004;127: 158-66.
23. M2 gangliosidosis. Hum Mutat 1998;11:432-42.
24. Brown CA, Mahuran DJ. β-Hexosaminidase isozymes from cells cotransfected with α and β cDNA constructs: analysis of the α-subunit missense mutation associated with the adult form of Tay-Sachs disease. Am J Hum Genet 1993;53:497-508.
25. Brittingham A, de la Cruz GP. Ancestry: 2000. http://www.census. gov/prod/2004pubs/c2kbr-35.pdf (Accessed May, 2006).
26. Brault GJ. The French-Canadian Heritage In New England. Hanover, NH: University Press of New England, 1986.
27. DeBraekeleer M, Hechtman P, Andermann E, Kaplan F. The French Canadian Tay-Sachs disease deletion mutation: identification of probable founders. Hum Genet 1992;89:83-7.
28. Hechtman P, Boulay B, DeBraekeleer M, Andermann E, Melancon S, Larochelle J, et al. The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada. Hum Genet 1992;90:402-6.
29. Hechtman P, Kaplan F, Bayleran J, Boulay B, Andermann E, DeBraekeleer M, et al. More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians. Am J Hum Genet 1990;47:815-22.
30. Fernandes M, Kaplan F, Natowicz M, Prence E, Kolodny E, Kaback M, et al. A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation. Hum Molec Genet 1992;1:759-61.
31. Akli S, Chelly J, Lacorte JM, Poenaru L, Kahn A. Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. Genomics 1991;11:124-34.
32. Trop I, Kaplan F, Brown C, Mahuran D, Hechtman P. A glycine250 to aspartate substitution in the α-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian Family. Hum Mutat 1992;1:35-9.
33. Karpati M, Peleg L, Gazit E, Akstein E, Goldman B. A novel mutation in the HEXA gene specific to Tay-Sachs disease carriers of Jewish Iraqi origin. Clin Genet 2000;57:398-400.
34. M2 ganglioside hydrolysis. J Mol Biol 2006;359:913-29.
35. Hechtman P, Boulay B, Bayleran J, Andermann E. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese. Clin Genet 1989;35:364-75.
36. M2 gangliosidosis B1 variant: biochemical and molecular characterization of hexosaminidase A. Biochem Mol Med 1995;54:126-32.
37. Proia RL, Neufeld EF. Synthesis of β-hexosaminidase in cell-free translation and in intact fibroblasts: an insoluble precursor α chain in a rare form of Tay-Sachs disease. Proc Natl Acad Sci U S A 1982;79:6360-4.
38. Palomaki GE, Williams J, Haddow JE, Natowicz MR. Tay-Sachs disease in persons of French-Canadian heritage in northern New England. Am J Med Genet 1995;56:409-12.
39. ACOG committee opinion. Number 318, October 2005. Screening for Tay-Sachs disease. Obstet Gynecol 2005;106:893-4.
40. Myerowitz R, Costigan FC. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the α-chain of β-hexosaminidase. J Biol Chem 1988;263:18587-9.